H-Orn(Fmoc)-OH is an Fmoc-protected ornithine derivative, where ornithine's side chain contains a primary amine and the α-amino group is protected as a fluorenylmethoxycarbonyl (Fmoc) carbamate, while the molecule retains a free carboxylic acid. The protected amino functionality is rendered less nucleophilic under peptide-coupling conditions, and the carboxyl group and side-chain primary amine provide defined sites for subsequent derivatization or incorporation into protected peptide-building blocks. This compound is used in stepwise peptide synthesis and related amino acid chemistry to control chemoselectivity during chain assembly and to introduce ornithine side-chain functionality for peptide analogues, chemical biology probes, or other structured peptide derivatives.
CAT No: CP26404
CAS No:147071-84-9
Synonyms/Alias:H-Orn(Fmoc)-OH;147071-84-9;N?-Fmoc-L-ornithine;ZINC2560767;7211AH;AKOS015909587;AK187050;FT-0697705;I14-32628
H-Orn(Fmoc)-OH is an Fmoc-protected ornithine derivative in which the side-chain primary amine of the amino acid scaffold is masked as an Fmoc carbamate, while the molecule retains a free carboxylic acid for controlled coupling chemistry. The structure therefore presents a single stereogenic center at the ornithine backbone (commonly supplied as a defined L-configuration) together with an orthogonally protected amino functionality that can be unmasked under peptide-synthesis conditions. The Fmoc group provides base-labile protection and a strong handle for iterative solid-phase or solution-phase peptide assembly, whereas the carboxylic acid supports activation to amide or ester intermediates. The combination of chiral amino acid architecture, protected side-chain reactivity, and acid functionality makes H-Orn(Fmoc)-OH a practical chiral building block for amino acid derivatization and downstream synthetic elaboration.
1. Peptide Synthesis
H-Orn(Fmoc)-OH is used in peptide synthesis workflows where Fmoc-based orthogonal protection is required for stepwise chain elongation and side-chain compatibility. The ornithine backbone provides a free carboxyl group for coupling, while the Fmoc-protected side-chain amine controls chemoselectivity during amide bond formation. Fmoc deprotection can be applied to expose the side-chain nucleophile for subsequent coupling steps, enabling incorporation of ornithine-derived motifs into peptides and peptidomimetics. Downstream, the resulting peptide intermediates can be carried forward to generate protected or partially deprotected sequences for biochemical research and structure-activity relationship studies.
2. Side-Chain Functionalization
H-Orn(Fmoc)-OH is suitable for side-chain functionalization strategies that rely on controlled activation of the ornithine carboxyl group and orthogonal unmasking of the protected amine. The Fmoc carbamate protects the primary amine during early stages of derivatization, reducing side reactions while the acid group can be converted to activated intermediates for amide formation. After Fmoc removal, the exposed amine can participate in conjugation, including formation of additional linkers, attachment handles for biomolecule labeling, or installation of polar/charged substituents relevant to molecular recognition. The resulting functionalized ornithine derivatives serve as intermediates for chemical biology probes, constrained peptide analogs, and synthetic scaffolds that incorporate amino acid side-chain chemistry.
3. Protected Amino Acid Chemistry
H-Orn(Fmoc)-OH functions as a protected amino acid intermediate for manufacturing and process chemistry routes that require predictable deprotection behavior and scalable protection/deprotection cycles. The Fmoc group provides a robust protecting-group strategy for the side-chain amine, while the free carboxylic acid supports standardized activation to amide-forming derivatives or ester intermediates. The chiral ornithine backbone supports stereodefined downstream products, which is particularly relevant when producing libraries of amino acid building blocks for peptide coupling chemistry. The compound can be employed to prepare N-protected ornithine-containing fragments that are compatible with common peptide coupling reagents and can be further transformed into protected or partially unprotected intermediates for fine chemical synthesis.
4. Bioconjugation Chemistry
H-Orn(Fmoc)-OH can be applied in bioconjugation chemistry where an amino acid-derived linker with orthogonally protected functionality is needed for controlled attachment to biomolecules. The protected side-chain amine helps manage chemoselectivity during linker synthesis, while the carboxylic acid enables formation of amide-linked conjugation handles or activated intermediates for subsequent coupling. Fmoc deprotection can reveal the nucleophilic amine for reaction with electrophiles such as activated esters or carbonyl-activated coupling partners used in labeling and probe construction. The resulting ornithine-based conjugates can serve as components of chemical biology tools, facilitating controlled modification of peptides, proteins, or other biomolecule scaffolds in applied research settings.
5. Pharmaceutical Manufacturing
H-Orn(Fmoc)-OH is relevant to pharmaceutical manufacturing contexts that involve peptide-like intermediates, peptidomimetic building blocks, or processable chiral amino acid derivatives. The Fmoc-protected amine and free carboxylic acid enable manufacturing-friendly intermediate design, including conversion to coupling-ready forms and controlled deprotection to expose reactive amine functionality at defined stages. The chiral ornithine framework supports consistent stereochemical outcomes when producing ornithine-containing fragments used in synthetic sequences for active pharmaceutical ingredient precursors or related process intermediates. The compound's protection strategy aligns with industrially common peptide synthesis logic, supporting downstream assembly of structured molecules used in research-grade and industrial fine chemical production.
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.